Myung Joo Kang's research interests include the design and evaluation of advanced long-acting injectable drug suspension; the design of a stable nanocarrier system for improved skin absorption; and the preformulation and formulation of chemicals and peptides via stabilizing and solubilizing techniques. Myung Joo Kang's publications include: Ho et al., Effect of particle size on in vivo performances of long-acting injectable drug suspension. J Control, 2022; Kim et al., Effect of Dispersion Medium on Pharmacokinetic Profile of Rotigotine Crystalline Suspension following Subcutaneous Injection. Pharmaceutics, 2022; Park et al., Design of Montelukast Nanocrystalline Suspension for Parenteral Prolonged Delivery. Int J Nanomedicine, 2022; Ho et al., Design and In Vivo Pharmacokinetic Evaluation of Triamcinolone Acetonide Microcrystals-Loaded PLGA Microsphere for Increased Drug Retention in Knees after Intra-Articular Injection. Pharmaceutics, 2019; Park et al., Effect of Penetration Enhancers on Toenail Delivery of Efinaconazole from Hydroalcoholic Preparations. Molecules, 2021; Lee et al., Montelukast microsuspension with hypromellose for improved stability and oral absorption. Int J Biol Macromol, 2021.